ThursdaySep 14, 2023 1:22 pm

QualityStocksNewsBreaks – American Rebel Holdings Inc. (NASDAQ: AREB) Completes $3.3M Warrant Inducement

American Rebel (NASDAQ: AREB, AREBW) is a designer, manufacturer and marketer of branded safes and personal security and self-defense products as well as branded apparel and accessories. The company recently completed a $3.3 million warrant inducement. EF Hutton, division of Benchmark Investments, LLC, acted as agent for the offering. For more information, visit https://ibn.fm/elxec About American Rebel Holdings Inc. American Rebel operates primarily as a designer, manufacturer and marketer of branded safes and personal security and self-defense products. The company also designs and produces branded apparel and accessories. To enhance the strength of its brand and drive product demand, the…

Continue Reading

ThursdaySep 14, 2023 11:47 am

QualityStocksNewsBreaks – New Orleans Investment Conference to Showcase Leading Minds at Forefront of Macroeconomic Analysis

The much-anticipated New Orleans Investment Conference 2023 — widely recognized as the “world’s greatest investment event” — is slated to take place from Nov. 1-4, 2023. At the heart of the financial and investing world for nearly five decades, this year’s event will provide more than 1,000 attendees the unique opportunity to engage with legendary market commentators, world-class analysts and the leading minds at the forefront of macroeconomic analysis. The roster for the event includes Lyn Alden, regarded as one of today’s most insightful and thought-provoking macro-economic analysts, Jim Iuorio, famed trader and outspoken market analyst for CNBC and Fox…

Continue Reading

ThursdaySep 14, 2023 11:01 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Releases Upcoming Destinations for 2023 Strikingly Different EV Experience

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is announcing new stops on its 2023 Strikingly Different EV U.S. tour. This month the EV experience will be in North Carolina as well as Washington, D.C., Philadelphia, New York City and Boston. This year’s Strikingly Different tour began in August, with its first stop in Austin, Texas; the innovative in-person tour is slated to go through November 2023 and includes destinations in the South and Midwest as well as on both the East and West Coasts. Announced tour stops in October include Detroit, Denver, Salt Lake City and Sonoma,…

Continue Reading

ThursdaySep 14, 2023 10:28 am

QualityStocksNewsBreaks – Near Intelligence Inc. (NASDAQ: NIR) Represents Commitment to Safeguard User Privacy with Announcement of New Position

Near Intelligence (NASDAQ: NIR), a data intelligence platform that curates one of the world’s largest sources of intelligence on people and places, has appointed current general counsel Jay Angelo as its new chief privacy officer; Angelo will continue to serve as general counsel as well. According to the announcement, the appointment of seasoned professional Angelo indicates Near’s commitment to safeguarding user privacy, a core pillar of the company’s foundation. The new role will facilitate and support Near’s privacy initiatives, ensuring that the company continues to uphold the highest standards of data protection and privacy compliance. A technology attorney with more than…

Continue Reading

ThursdaySep 14, 2023 9:52 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Plaque Psoriasis Treatment Study

Scinai Immunotherapeutics(NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, is reporting encouraging results from its preclinical study of Scinai’s anti‑interleukin 17 (IL‑17) NanoAbs as a treatment for plaque psoriasis. According to the report, study results suggest that the NanoAbs, or nanosized VHH antibodies, have potential to relieve symptoms of plaque psoriasis. Currently, there is no safe, affordable biological drug available to treat mild psoriasis, which accounts for 50% of plaque psoriatic patients, has no safe and affordable biological drug available. Scinai’s…

Continue Reading

ThursdaySep 14, 2023 9:45 am

Longeveron Inc. (NASDAQ: LGVN) to Discuss Its Cellular Therapy Programs, Clinical Trial Progress at the 25th Annual H.C. Wainwright Global Investment Conference

Longeveron management will present at the 25th Annual H.C. Wainwright Global Investment Conference scheduled for September 11-13, 2023, in New York Wa’el Hashad, the company’s CEO, will discuss Longeveron’s cellular therapy programs in a pre-recorded presentation. Both he and Lisa Locklear, EVP & Chief Financial Officer, will be at the conference to discuss the company’s investment strategies and clinical trial progress The company aims to create awareness among scientists and investors of its clinical trial progress, positive clinical results, and cellular therapy programs Longeveron is evaluating its lead investigational product candidate, a cellular product named Lomecel-B(TM), in ongoing clinical trials…

Continue Reading

ThursdaySep 14, 2023 9:21 am

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Superior Coherence Performance with Fluxonium Qubits

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, has announced notable progress in its development of high coherence qubits. D-Wave has designed, manufactured and operated fluxonium qubits that have demonstrated quantum properties that are comparable to the best seen to date in scientific literature, and the results are expected to have a significant impact on its future quantum technologies. “These results show that fluxonium is a viable candidate qubit for D-Wave’s gate model quantum computing architectures. Moreover, in doing this work we have learned that fluxonium can…

Continue Reading

ThursdaySep 14, 2023 9:00 am

Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development

U.S.-based generic drug developer SOHM recently announced the addition of two leading officers — Dr. David Aguilar (Ph.D) as Chief Operating Officer and Dr. Krishna Bhat (MD, Ph.D, FACC) as Chief Medical Advisor The new officers are expected to help direct SOHM’s global growth strategy as the company continues to develop and diversify its product offerings, which include a variety of mediums for administering antibiotics, analgesics, anti-inflammatory and anti-cold therapies, as well as vitamins SOHM also recently announced an LOI to acquire a stem cell disruptive technology and related patents, which include the potential for someday treating damaged hearts via…

Continue Reading

WednesdaySep 13, 2023 1:47 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Unveils Grant Program to Ensure School Safety

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced the launch of its School Safety Grant Program. According to the announcement, Knightscope’s program makes the safety of schools, children and teachers a top priority and is designed to empower individuals and promote safer learning environments in K-12 schools. Knightscope understands that violence, harassment and threats against students, teachers and school staff have a significant negative impact on the ability for children to obtain a quality education in a safe environment. Creating a supportive school culture is the first line of defense,…

Continue Reading

WednesdaySep 13, 2023 11:13 am

QualityStocksNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Announces Acquisition of BlueSky Wellness, Expands Footprint in Global Wellness Market

Lucy Scientific Discovery (NASDAQ: LSDI), a publicly traded company focused on the development, sale, delivery and manufacturing of psychotropic products, is acquiring BlueSky Wellness Inc. and the BlueSky portfolio of brands. According to the announcement, the acquisition adds psychotropic products to the company’s catalog, enabling LSDI to expand its footprint in the global wellness market. BlueSky Wellness brands include Keoni, Keoni Sport, Blush Wellness and AMMA Healing, which have generated more than $20 million in revenue in each of the last two years; BlueSky products range from full-spectrum oils to edible goods, gummies, topicals and beauty products. As part of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered